SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001493152-21-001110
Filing Date
2021-01-14
Accepted
2021-01-14 21:32:36
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11526
2 corresp_001.jpg GRAPHIC 5133
  Complete submission text file 0001493152-21-001110.txt   19736
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations